Related Experiment Video

Updated: Oct 1, 2026

Direct Detection of Isolevuglandins in Tissues Using a D11 scFv-Alkaline Phosphatase Fusion Protein and Immunofluorescence
06:33

Direct Detection of Isolevuglandins in Tissues Using a D11 scFv-Alkaline Phosphatase Fusion Protein and Immunofluorescence

Published on: July 5, 2021

Effects of reactive gamma-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway

Sean S Davies1, Ventkataraman Amarnath, Kathleen S Montine

  • 1Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 27232-6602, USA.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|April 30, 2002
PubMed

Insights

Reactive aldehydes, isoketals (IsoKs), impair proteasome function by hindering protein degradation. This inhibition, observed in neuroglial cells, suggests a role for IsoKs in neurodegenerative disease pathogenesis.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Cell Biology

Background:

  • Oxidative stress and impaired proteasome function are hallmarks of neurodegenerative diseases.
  • Free radical-induced lipid peroxidation generates reactive aldehydes like isoketals (IsoKs) and neuroketals (NeuroKs).
  • These compounds are analogous to cyclooxygenase-derived levuglandins (LGs).

Purpose of the Study:

  • To investigate the proteasome's ability to degrade IsoK-adducted proteins/peptides.
  • To determine the effect of IsoKs and their adducts on proteasome function.
  • To explore the potential role of IsoKs in neurodegenerative disease pathogenesis.

Main Methods:

  • Assessing the degradation rates of IsoK-adducted model proteasome substrates by the 20S proteasome.
  • Evaluating the direct inhibitory effect of IsoKs on proteasome activity.
  • Measuring the impact of IsoK-adducted proteins/peptides on the chymotrypsin-like activity of the 20S proteasome.
  • Assessing IsoK's effect on proteasome activity and cell viability in P19 neuroglial cultures.

Main Results:

  • Adduction of IsoK to substrates significantly reduced their degradation rate by the 20S proteasome.
  • IsoK-adducted ovalbumin and Ab1-40 peptide significantly inhibited the chymotrypsin-like activity of the 20S proteasome at low concentrations.
  • IsoK directly inhibited proteasome function only at very high concentrations.
  • In neuroglial cultures, IsoK dose-dependently inhibited proteasome activity (IC50 = 330 nM) and induced cell death (LC50 = 670 nM).

Conclusions:

  • IsoKs and related compounds can inhibit proteasome activity.
  • Overproduction of IsoKs may contribute to the pathogenesis of neurodegenerative diseases.
  • IsoK-adducted proteins and peptides impair proteasome function, potentially leading to cellular dysfunction and death.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...